Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20172889 | 0.89 | ALDH1A1 (0.34) | POLBMAPTALDH1A1NPSR1 | |
| SCHEMBL20172885 | 0.88 | ACHE (0.37) | ACHEPOLBMAPTLMNAALDH1A1 | |
| SCHEMBL20172875 | 0.87 | CYP1A2 (0.35) | ALDH1A1NPSR1CYP2A6CYP1A2 | |
| SCHEMBL20650364 | 0.84 | ACHE (0.36) | ACHEPOLBMAPTLMNAALDH1A1 | |
| SCHEMBL20172871 | 0.83 | GPR3 (0.39) | POLBMAPTALDH1A1NPSR1 | |
| SCHEMBL21021492 | 0.81 | CHKA (0.36) | ALDH1A1CYP2A6CYP1A2 | |
| SCHEMBL21020013 | 0.81 | ALDH1A1 (0.37) | POLBMAPTALDH1A1NPSR1CYP1A2 | |
| SCHEMBL20172939 | 0.81 | ALDH1A1 (0.31) | POLBALDH1A1NPSR1 | |
| SCHEMBL20172916 | 0.81 | ACP1 (0.33) | POLBALDH1A1NPSR1CYP1A2 | |
| SCHEMBL20172911 | 0.81 | ALDH1A1 (0.33) | POLBALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651411-B2 | Compound and organic light emitting device containing same | LG CHEM, LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | CRY1, CRY2, OR10J3 | ACHE 337/4885POLB 3877/4885MAPT 754/4885 |
| US-10651411-B2 | Compound and organic light emitting device containing same | CRY1, CRY2, OR10J3 | ACHE 337/4885POLB 3877/4885MAPT 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.